Related references
Note: Only part of the references are listed.Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Ioana Agache et al.
ALLERGY (2020)
Intersection of biology and therapeutics: type 2 targeted therapeutics for adult asthma
Michael C Peters et al.
LANCET (2020)
New Insights into Asthma Inflammation: Focus on iNKT, MAIT, and γδT Cells
Jefferson Russo Victor et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Evidence for a MAIT-17-high phenotype in children with severe asthma
Guillaume Lezmi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Immunologic mechanisms in asthma
Tadech Boonpiyathad et al.
SEMINARS IN IMMUNOLOGY (2019)
Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma
Marina Pretolani et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms
Timothy S. C. Hinks et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Functions of T cells in asthma: more than just TH2 cells
Clare M. Lloyd et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Share Paper
